Curia Appoints Philip Macnabb as Chief Executive Officer
Philip Macnabb Philip Macnabb appointed CEO of Curia ALBANY, N.Y., March 16, 2023 (GLOBE NEWSWIRE)…
Year: 2023
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Allbirds, Inc. (BIRD) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
crypto.ro Announces ‘The Alliance’, the Most Anticipated Crypto Conference in 2023
TIMISOARA, Romania, Mar 17, 2023 – (ACN Newswire) – Crypto.ro, Romania’s leading cryptocurrency and blockchain…
SmartStop Self Storage Wins Reputation’s 800 Award for Second Consecutive Year
LADERA RANCH, Calif.–(BUSINESS WIRE)–SmartStop Self Storage REIT, Inc. (“SmartStop” or the “Company”), a self-managed and…
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced…
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced…
Jounce Therapeutics Announces Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab Demonstrating Deep and Durable Responses in Platinum Resistant Ovarian Cancer
Ovarian Combination Cohort Target Lesion % Change from Baseline over Time Ovarian Combination Cohort Target…
Jounce Therapeutics Announces Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab Demonstrating Deep and Durable Responses in Platinum Resistant Ovarian Cancer
Ovarian Combination Cohort Target Lesion % Change from Baseline over Time Ovarian Combination Cohort Target…
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY, March…
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY, March…
Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship
Provides $10 million upfront cash commitment to Lifecore for infrastructure preparation and production capacity preparation…
Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship
Provides $10 million upfront cash commitment to Lifecore for infrastructure preparation and production capacity preparation…
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET SAN…
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET SAN…
Lifecore Biomedical Announces Intent to Explore Strategic Alternatives
CHASKA, Minn., March 16, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (“Lifecore” or the “Company”),…
Lifecore Biomedical Announces Intent to Explore Strategic Alternatives
CHASKA, Minn., March 16, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (“Lifecore” or the “Company”),…
Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results
Company Announces Intention to Explore Strategic AlternativesSigns Term Sheet with Key Customer to Materially Expand…
Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results
Company Announces Intention to Explore Strategic AlternativesSigns Term Sheet with Key Customer to Materially Expand…
Novan Announces Closing of $6.0 Million Registered Direct Offering
DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…
Novan Announces Closing of $6.0 Million Registered Direct Offering
DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…